Carbendazim in Treating Patients With Advanced Solid Tumors or Lymphoma
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die.
PURPOSE: Phase I trial to study the effectiveness of carbendazim in treating patients who
have advanced solid tumors or lymphoma.